Under a Mask of AI Doomerism, the Familiar Face of Eugenics
By Émile P. Torres,
Truthdig
| 10. 17. 2025
In a new book, Eliezer Yudkowsky and Nate Soares hide their radical transhumanist agenda under the cover of concern about “AI safety.”
The Internet philosopher Eliezer Yudkowsky has been predicting the end of the world for decades. In 1996, he confidently declared that the singularity — the moment at which computers become more “intelligent” than humanity — would happen in 2021, though he quickly updated this to 2025. He also predicted that nanotechnology would suddenly emerge and kill everyone by 2010. In the early aughts, the self-described “genius” claimed that his team of “researchers” at the Singularity Institute would build an artificial superintelligence “probably around 2008 or 2010,” at which point the world would undergo a fundamental and irreversible transformation.
Though none of those things have come to pass, that hasn’t deterred him from prophesying that the end remains imminent. Most recently, he’s been screaming that advanced AI could soon destroy humanity, and half-jokingly argued in 2022 that we should accept our fate and start contemplating how best to “die with dignity.”
Yudkowsky carries on his indefatigable doomsaying in a new book, co-written with his fellow apocalypticist Nate Soares, “If Anyone Builds It, Everyone Dies.” The conclusion is in...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...